![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 Targeting HER2 Mutation-Positive Advanced Biliary Tract Cancers With Neratinib: Final Results From the Phase 2 SUMMIT Basket Trial
By
ASCO 2022 Conference Coverage
FEATURING
James Harding
By
ASCO 2022 Conference Coverage
FEATURING
James Harding
81 views
June 15, 2022
Login to view comments.
Click here to Login
GI